Bothell, WA, United States of America

Ryan Lyski

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Seagen Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan Lyski. Retrieved from https://idiyas.com/inventor/ryan-lyski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryan Lyski: Innovator in Antibody Conjugates

Introduction

Ryan Lyski is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Ryan Lyski holds a patent for "Camptothecin conjugates." This patent describes antibody conjugates with camptothecin compounds, along with methods of use and preparations. His work in this area highlights the potential for improved therapeutic options in cancer treatment.

Career Highlights

Ryan is currently employed at Seagen Inc., a leading biotechnology company focused on developing innovative therapies for cancer. His role at Seagen allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical advancements.

Collaborations

Ryan has worked alongside esteemed colleagues such as Scott C Jeffrey and Uland Lau. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Ryan Lyski is a dedicated inventor whose work in antibody conjugates has the potential to impact cancer treatment significantly. His contributions to the field, along with his collaborations at Seagen Inc., underscore his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…